Chapter 17 Beifeng Pharmaceutical’s counterattack!
There is no mandatory requirement for clinical trial data of innovative drugs to be disclosed to the public, whether in the United States or China.
The reason is very simple.
The second and third clinical phases of each innovative drug are trials conducted by pharmaceutical companies that invest a lot of real money, and the data obtained are naturally regarded as pharmaceutical companies. of intangible assets.
Moreover,
Clinical data is of great significance to the research and development of new drugs. For example, some companies that develop drugs for the same target can easily judge the other party's research and development progress through the other party's clinical data.
On this basis, they can even use the other party's clinical data to conduct deeper research and development, quickly obtain patents for newer drugs, and thereby gain competitive advantages.
Of course.
Zhang Yang has no such worries at all.
On the contrary, he needs to publish the second phase clinical data,
He knew very well that he was already short of funds. If "Qingshan Avatrombopag" wanted to continue to open the third phase of clinical trials, he had to negotiate deals with other pharmaceutical companies.
Zhang Yang’s plan was quickly realized. After most of the data on “Avatrombopag Qingshan” was published on the website, it quickly aroused strong attention in the industry.
Suzhou, Hengrui Pharmaceutical Headquarters.
Hengrui Pharmaceuticals is considered to be the top pharmaceutical research and development company in China.
Compared with other domestic pharmaceutical companies that only focus on the research and development of proprietary Chinese medicines and generic drugs with lower risks, Hengrui not only invests a large amount of money in innovative drugs every year, but also in major diseases such as tumors and cancers. Good results were achieved.
Several of its oncology drugs have been launched domestically, and some are even sold overseas.
At this time, two middle-aged men were discussing in the president's office on the 17th floor of the Hengrui headquarters building.
"Wen Ping, two people, one is a second-level drug researcher and the other is an ordinary manager, can develop 'Avatrombopag'? Do you believe it?"
The speaker is Heng Rui President Su Lin.
As a person with a background in technology research and development, Su Lin did not discuss the commercial value behind "Avatrombopag" at the first time, but first questioned the rationality.
"I don't believe it either. It sounds really outrageous."
Su Wenping showed a wry smile and shook his head:
"Let's not talk about other things first, just the screening of compounds and the laboratory The data cannot be completed by two people, but..."
“I specifically checked the patent they applied for, and both the crystal form and the compound are indeed completely different from ‘Avatrombopag’ developed by AkaRx.
I can only say This man is a genius!”
"Genius?"
Su Lin shook his head jokingly, obviously not believing it at all.
“Okay, it doesn’t matter whether it’s genius, luck, or where you picked it up. In short, this new drug has appeared!”
“Wen Ping, tell me about you Let’s think about it, should we buy this drug patent or discuss cooperation?”
Su Wenping is the head of Hengrui’s BD trading department.
Hearing this, he nodded without hesitation, and his eyes fell on the clinical data of "Qingshan Avatrombopag Tablets" again, with a hint of amazement still in his eyes!
"Mr. Su, the clinical data of this new drug are really beautiful!"
"Most of its data not only reach the level of AkaRx's 'Avatrombopag' The effect, and even some clinical effects are slightly exceeded, it is no exaggeration to call it the domestic version of 'Avatrombopag' ”
"At present, our company's star products are mainly oncology drugs. If we can introduce this 'Avatrombopag', it will undoubtedly bring fresh blood to the company's entire product series."
"So, I very much agree with buying this drug patent. At the very least, I have to find a way to discuss cooperation with them! ”
Su Lin nodded.
After a while, he said:
"Well, I'll leave this matter to you. You need to contact them first, find out what they are talking about, and see if they are willing to sell!"
“Okay, I’ll do it myself!”
……
The conversations between Hengrui’s top executives are just the tip of the iceberg for the entire industry.
As the clinical phase II data of "Qingshan Avatrombopag" spread in the industry, several other innovative drug companies in China have also held similar meetings.
All meetings have only one topic - to make contact and see if we can acquire patents. Of course, Beifeng Pharmaceutical naturally noticed such a big movement.
In the office, Ding Jian looked cold.
Ever since He Youcai was mercilessly attacked by Zhang Yang a few days ago, his mood has been extremely gloomy.
I originally wanted to see if I could find a breakthrough from Ren Xiaomin, but before I took action, Zhang Yang disclosed the second phase data of "Qingshan Avatrombopag".
This announcement obviously disrupted his plan. Now all pharmaceutical companies are eyeing "Avatrombopag", and it is almost impossible for him to buy it at a low price!
“Boss, what should we do now?”
“Zhang Yang’s attitude towards us is already very bad. If other pharmaceutical companies come into contact with them now, we may have no chance at all! ”
The speaker was He Youcai. When the news came, he became a little anxious knowing the inside story.
Ding Jian had a sullen face and did not answer.
"How about...Boss, let's talk to them again quickly?"
"This time we offer a good price, and my attitude will be lower...No, I Apologize to them in person!”
“Apologise?”
Ding Jian finally spoke.
“How many times have I told you, don’t panic when something happens!”
“Just think about it when we contacted them a few days ago, they were so arrogant and domineering. Now we don’t know How many pharmaceutical companies are contacting them, do you think they will give us a good look? "
" Talking to them now will only leave the initiative in their hands and be completely led by their noses! "
He Youcai suddenly woke up after hearing this.
This is indeed the truth. When I contacted Zhang Yang a few days ago, the two parties were at least on an equal footing. Now the other party has risen and is waiting for a price. If we continue to negotiate, it will be passive!
"Boss, what should we do next?"
"We can't just watch other pharmaceutical companies contact Zhang Yang and conclude a deal, right?"
"Of course No!"
Ding Jian fell into thought, frowning, and after a few minutes he suddenly whispered:
"What's their biggest problem now?"
"Insufficient funds!" He Youcai said anxiously.
"That's right."
Ding Jian's eyes gradually became fierce:
"Let this news out and let everyone know that their funds are broken and they have no money to do anything else. Clinical Phase III! ”
"In this way, after those old guys know about it, no one will be willing to pay a high price to Zhang Yang. I know them very well. None of them are fuel-efficient!"
He Youcai was stunned for a moment. , and then he was amazed in his heart!
Now other pharmaceutical companies don’t know the details of Zhang Yang, and they are all begging Zhang Yang to sell the drug patent to them.
But once these pharmaceutical companies know that Zhang Yang has no money to promote the next clinical trial, the nature will be completely different!
From waiting for a price to selling, it turned into having to sell!
The price is so different!
Once the price expectations differ too much, the negotiation will inevitably fail!
High!
It’s so high!
Thinking of this, he couldn't help but glance at his boss Ding Jian. With this move, Zhang Yang immediately changed from active to passive!
But at this moment, Ding Jian continued:
“This is not enough!”
“If you have money, don’t we have some connections in the clinical trial review center?”
"Go and move!"
(End of this chapter)